Back to search

Switzerland· 56527015

Simvastatin Zentiva 40 mg, Filmtabletten

A simvastatin product containing simvastatinum, registered in Switzerland by Helvepharm AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C10AA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSimvastatin Zentiva 40 mg, Filmtablet…ATCC10AA01REGISTER NO.56527015PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Simvastatin is registered in 17 of 19 countries.

Countries holding a registration under ATC C10AA01 (simvastatin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 10 of them publish a price we can compare per daily dose

Simvastatin · ATC C10AA01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of simvastatin costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.17 in France to $0.97 in Switzerland — a ×5.9 gap.

  • Switzerland: $0.97 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Simvastatin · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.97
  • IT Italy$0.33
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
simvastatinum
Manufacturer
Helvepharm AG
Country
Switzerland (CH)
ATC code
C10AA01
ATC class
Simvastatin
Defined daily dose
30 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680565270150
    Blist 98 Stk
    CHF 61.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

889 interactions on record for simvastatin.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Simvastatin · interactions on record

889 records

  • 59 severe
  • 253 moderate
  • 10 minor
  • 513 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • AmiodaroneC01BD01severe
  • DronedaroneC01BD07severe
  • RanolazineC01EB18severe

54 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Simvastatin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Gerosim, Simvastad
  • Belgium · Cholemed, Simvastatin Ab
  • Bulgaria · Simvacor 10 Mg, Simvacor 20 Mg
  • Cyprus · Kymazol, Priacin
  • Czechia · Simvastatin Ratiopharm, Simvastatin Viatris
  • Germany · Simva, Simva Tad
  • Denmark · Perichol, Simvastatin Hexal
  • Estonia · Simvacor, Simvastatin Ratiopharm
  • Spain · Alcosin, Pantok
  • Finland · Lipcut, Simvastatin Krka
  • France · Simvastatine Accord Healthcare, Simvastatine Almus
  • United Kingdom (Northern Ireland) · Ranzolont, Simvastatin
  • Greece · Antichol, Bevostatin
  • Croatia · Lipex, Lipterra
  • Hungary · Sicor, Simvacol
  • Ireland · Simtan, Simvastatin Bluefish
  • Iceland · Simvastatin Actavis, Simvastatin Bluefish
  • Italy · Alpheus, Krustat
  • Lithuania · Simvacor
  • Luxembourg · Simvastatin Ratiopharm, Simvastatin Sandoz
  • Latvia · Simvacor
  • Malta · Priacin, Simtan
  • Netherlands · Simvastatin Aurobindo, Simvastatin Teva
  • Norway · Simvastatin Bluefish, Simvastatin Hexal
  • Poland · Apo-Simva, Simcovas
  • Portugal · Simvastatin Ratiopharm, Simvastatina Ratiopharm
  • Romania · Simvacard, Simvastatin Terapia
  • Sweden · Simvastatin Bluefish, Simvastatin Brown
  • Slovenia · Simvastatin Lek, Sinvacor
  • Slovakia · Simvacard, Simvastatin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b43ffab9-dd66-47d7-83da-75d5e28fe399
GET /v1/drugs/b43ffab9-dd66-47d7-83da-75d5e28fe399?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "simvastatinum 40 mg",
  "valid_from": "2022-01-01",
  "limitations": "[{\"description\":\"Bei Erwachsenen ab 18 bis und mit 75 Jahren wird eine Behandlung mit Statinen vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie sowie bei Personen mit einem Risiko von über 1% nach AGLA-Risikokategorie. Eine entsprechend bis und mit 75 Jahren gestartete Statin-Therapie wird auch nach Vollendung des 75. Lebensjahres weiter vergütet.<br>\\nBei Personen über 75 Jahren wird eine neu beginnende Statin-Therapie nur vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie.<br>\\nSimvastatin Zentiva wird zudem vergütet bei Kindern und Jugendlichen im Alter von 10-17 Jahren bei heterozygoter familiärer Hypercholesterinämie zusätzlich zur Diät, wenn diese und andere nicht-pharmakologische Massnahme (wie Fitnesstraining und Gewichtsreduktion) keine ausreichende Wirkung erbringen. Jungen sollten mindestens im Tanner-Stadium II sein. Mädchen sollten mindestens 1 Jahr nach der Menarche sein.<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2022-08-01\"}]",
  "galenic_form": "Filmtabl 40 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2015-04-01",
  "self_retention_pct": 10
}

See everything about simvastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.